Methotrexate monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Full blood count, liver tests and renal function at agreed intervals
Stable low-dose methotrexate still requires periodic FBC, liver-function and renal-function monitoring because marrow suppression, hepatotoxicity and accumulation can occur. Frequency follows specialist or shared-care guidance and increases after dose changes or when risk factors emerge.
Reference: BNF: methotrexate: https://bnf.nice.org.uk/drugs/methotrexate/